(1 - 9 from 9
)
Roche to cut costs, review business after drug setbacks
www.reuters.com
analysts Odile Rundquist and Karl-Heinz Koch. Roche stock traded 1.8 percent at GMT, outperforming a 0.4 percent rise in the European healthcare index. Roche stock has slipped over 20 percent so far this year, ...
sorted by relevance / date